Recent Finacing
Recent Raise
AffyXell is a joint venture between Avacta and Daewoong developing genetically engineered mesenchymal stem cells that secrete Affimer proteins to modulate immune responses for inflammatory, autoimmune, and transplant indications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors